• Skip to main content
  • Skip to after header navigation
  • Skip to site footer
ERN: Emerging Researchers National Conference in STEM

ERN: Emerging Researchers National Conference in STEM

  • About
    • About AAAS
    • About the NSF
    • About the Conference
    • Partners/Supporters
    • Project Team
  • Conference
  • Abstracts
    • Undergraduate Abstract Locator
    • Graduate Abstract Locator
    • Abstract Submission Process
    • Presentation Schedules
    • Abstract Submission Guidelines
    • Presentation Guidelines
  • Travel Awards
  • Resources
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP/CREST PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us
  • Login

Cyclospora Laboratory Assessment Survey (CLAS) of United States Laboratories

Undergraduate #20
Discipline: Biological Sciences
Subcategory: Microbiology/Immunology/Virology

Moses Akintunde - Pennsylvania State University
Co-Author(s): Marc Roger Couturier, University of Utah, Salt Lake City, UT Francisca Abanyie, Centers for Disease Control and Prevention (CDC) Atlanta, GA



Cyclosporiasis is a gastrointestinal illness caused by the protozoan parasite Cyclospora cayetanensis. Over the past twenty-five years, the United States has reported several outbreak-related cases, including recent outbreaks in 2013, 2014, and 2015. A survey conducted in 2000 evaluated U.S. laboratory practices for identifying Cyclospora in stool specimens. The survey found that 36% of laboratories tested for C. cayetanensis on-site; <7% tested fecal specimens for C. cayetanensis as part of routine O&P and 27% tested for the parasite upon request. To assess the current diagnostic capabilities and practices of laboratories examining stool for Cyclospora, American Society for Microbiology (ASM) conducted a nationwide survey of laboratories in the United States and outlying territories over a 1-month period. In total, 125 (87%) of the 143 participants who initiated the survey completed the survey. Of 136 respondents, 62% were microbiologists and 23% were clinical laboratory scientists or medical technologists. Participants of the survey were from 42 of the 56 (75%) states and territories, with the majority of respondents from Southern (32.1%) and Midwestern (29.1%) states. Most respondents described their laboratory as being affiliated with a community hospital (46%) or a university hospital (25%). The majority of respondents’ laboratories (60%) diagnosed cyclosporiasis on-site. Of 119 respondents who reported that their laboratories accepted stool specimens for parasitologic testing, 17% (20 of 115 respondents) stated their laboratory examined Cyclospora oocysts as part of routine ova and parasite analysis; 41% (47 of 115 respondents) performed testing by request only. Microscopy by modified acid-fast staining was the most commonly used diagnostic test (74%; 48 of 65 respondents), followed by Biofire Diagnostic’s FilmArray® Gastrointestinal Panel (FilmArray® GP) (12%; 8 of 65 respondents). Fifty-two percent (34 of 65 respondents) reported that their laboratory has at least two different tests available for identification of Cyclospora. Over the one-year period prior to the survey 33% of respondents (34 of 104 respondents) stated their laboratory reported at least one positive stool specimens for Cyclospora. Of those reporting positive cases, 82% (28 of 34 respondents) had between 1 to 10 positive tests. Compared to the survey conducted in 2000, some progress has been made in incorporating Cyclospora into routine ova and parasite analysis. New clinical laboratory tests such as the FilmArray® GP may help fill the gaps between testing and diagnosis. Overall, the results of this survey emphasize the need for capacity building for Cyclospora in U.S. laboratories. These results will assist ASM and CDC in developing targeted educational and training opportunities for laboratory personnel.

Funder Acknowledgement(s): I would like to thank the IMHOTEP summer program for affording me the wonderful opportunity to work along with Francisca Abanyie, MD, MPH (CGH | DPDM), Marc Roger Couturier, PhD, D(ABMM) (ASM), Rebecca Hall, MPH (CGH| DPDM), and Barbara Herwaldt, MD, MPH (CGH| DPDM).

Faculty Advisor: Francisca Abanyie,

Sidebar

Abstract Locators

  • Undergraduate Abstract Locator
  • Graduate Abstract Locator

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW
Washington,DC 20005
202-326-6400
Contact Us
About Us

  • LinkedIn
  • Facebook
  • Instagram
  • Twitter
  • YouTube

The World’s Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

Focus Areas

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law

© 2023 American Association for the Advancement of Science